BTX Stock Analysis: BlackRock Technology | NYSE
Asset Management | NYSE, USA | Market Cap: 1.045m USD | 12M Return: 49.4% | US09260Q1085 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.55M
Warnings
Tailwinds
Seasonality 5.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
BlackRock Technology and Private Equity Term Trust (NYSE: BTX) is a fund launched by BlackRock, Inc. and managed through its subsidiary, BlackRock Advisors, LLC. The fund is domiciled in the United States and trades as common stock with a market capitalization of approximately $1,045 million USD. According to GICS classification, it falls within the Health Care sector and Biotechnology sub-industry. As an exchange-listed fund, it provides investors with exposure to a portfolio of biotechnology companies, a sector that typically focuses on the research, development, and commercialization of therapies and drugs derived from biological processes, often characterized by long development cycles and reliance on clinical and regulatory milestones.
- Tech holdings rally boosts portfolio NAV
- Discount to NAV narrows on rate cut optimism
- Distribution yield supports investor demand
| Net Income: -44.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -0.67 > 1.0 |
| NWC/Revenue: -1.51k% < 20% (prev -12.83%; Δ -1.50k% < -1%) |
| CFO/TA -0.02 > 3% & CFO -17.0m > Net Income -44.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.13 > 1.5 & < 3 |
| Outstanding Shares: last quarter (116.7m) vs 12m ago 2.06k% < -2% |
| Gross Margin: -97.99% > 18% (prev 99.19%; Δ -197.2% > 0.5%) |
| Asset Turnover: 0.04% > 50% (prev 2.25%; Δ -2.21% > 0%) |
| Interest Coverage Ratio: -11.28 > 6 (EBIT TTM -41.3m / Interest Expense TTM 3.66m) |
| A: -0.01 (Total Current Assets 1.39m - Total Current Liabilities 10.4m) / Total Assets 939.0m |
| B: -2.04 (Retained Earnings -1.92b / Total Assets 939.0m) |
| C: -0.03 (EBIT TTM -41.3m / Avg Total Assets 1.37b) |
| D: 38.95 (Book Value of Equity 915.5m / Total Liabilities 23.5m) |
| Altman-Z'' = 33.97 = AAA |
As of October 07, 2026, the stock is trading at USD 9.49 with a total of 475,958 shares traded. Over the past week, the price has changed by +6.03%, over one month by +5.98%, over three months by +11.22% and over the past year by +49.37%.
Current recommended Stop Loss: 9.20 (which is 3.1% or 1.6 ATR below the current price).
BlackRock Technology has no consensus analysts rating.
| Analysts Target Price | 3 | -68.4% |
P/E Trailing = 2.3008
P/S = 2.352
P/B = 0.84
Revenue TTM = 598k USD
EBIT TTM = -41.3m USD
EBITDA TTM = -39.2m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 2.76m USD (Leases only: 2.76m)
Net Debt = 2.31m USD (calculated: Debt 2.76m - CCE 449k)
Enterprise Value = 1.05b USD (1.04b + Debt 2.76m - CCE 449k)
Interest Coverage Ratio = -11.28 (Ebit TTM -41.3m / Interest Expense TTM 3.66m)
EV/FCF = -60.37x (Enterprise Value 1.05b / FCF TTM -17.3m)
FCF Yield = -1.66% (FCF TTM -17.3m / Enterprise Value 1.05b)
FCF Margin = -2.90k% (FCF TTM -17.3m / Revenue TTM 598k)
Net Margin = -7.51k% (Net Income TTM -44.9m / Revenue TTM 598k)
Gross Margin = -97.99% ((Revenue TTM 598k - Cost of Revenue TTM 1.18m) / Revenue TTM)
Gross Margin QoQ = none% (prev -102.1%)
Tobins Q-Ratio = 1.11 (Enterprise Value 1.05b / Total Assets 939.0m)
Interest Expense / Debt = 132.4% (Interest Expense 3.66m / Debt 2.76m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -32.6m (EBIT -41.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.13 (Total Current Assets 1.39m / Total Current Liabilities 10.4m)
Debt / Equity = 0.00 (Debt 2.76m / totalStockholderEquity, last quarter 915.5m)
Debt / EBITDA = -0.06 (negative EBITDA) (Net Debt 2.31m / EBITDA -39.2m)
Debt / FCF = -0.13 (negative FCF - burning cash) (Net Debt 2.31m / FCF TTM -17.3m)
Total Stockholder Equity = 1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -3.27% (Net Income -44.9m / Total Assets 939.0m)
RoE = -4.21% (Net Income TTM -44.9m / Total Stockholder Equity 1.07b)
RoCE = -4.44% (EBIT -41.3m / Capital Employed (Total Assets 939.0m - Current Liab 10.4m))
RoIC = -3.51% (negative operating profit) (NOPAT -32.6m / Invested Capital 928.5m)
WACC = 11.76% (E(1.04b)/V(1.05b) * Re(11.79%) + (debt cost/tax rate unavailable))
Discount Rate = 11.79% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 72.26 | Cagr: 301.1%
[DCF] Fair Price = unknown (Cash Flow -17.3m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.22 | # QB: 0
Revenue Correlation: -99.69 | Revenue CAGR: -76.92% | SUE: N/A | # QB: 0